Uncategorized

We are thrilled to announce that Approxima has been selected as one of the top innovators in the medtech industry, earning us a spot to showcase our technology at the prestigious MedTech Innovator Road Tour 2024 in Dublin on April 15, during the International Pitch Event.

Approxima is currently participating in the MedTech Strategist Innovation Summit in Dublin 2024, a remarkable event for medtech innovations.

We are delighted to inform you that Dr. Paolo Denti, our Chief Medical Officer, will be presenting the latest advancements of the Approxima technology at the upcoming hasztag#InnovatorsDay and hasztag#EuroPCR conference in Paris next week! 🔍 Our ePoster will be displayed throughout the duration of both Innovators Day and Euro PCR on touchscreens, offering attendees

We are honoured to announced that the Scientific Board of Approxima has been joined by two interventional cardiologists distinguished KOLs in the structural heart field:– Prof. Nicolas Van Mieghem – Full Professor of Inteventional Cardiology at Erasmus MC in Rotterdam, Netherlands– Dr. Federico De Marco – Director of Interventional, Valvular and Structural Heart Cardiology at

Approxima takes the stage at PCR London Valve 2023, the leading conference in transcatheter heart valve therapies, kicking off on Sunday, 19/11/2023.Approxima’s abstract has been handpicked by the Selection Committee as one of this year’s Top Innovations! Dr. Paolo will present our preclinical data for the first time in a public setting at the Top Innovations

Approxima closed a € 1.6M seed financing round for the development of its minimally invasive tricuspid valve repair technology and strengthens the team with both a new Chairman of the Board and a CMO. • The seed financing round was led by Panakès Partners alongside Club degli Investitori and a group of business angels. •

Approxima will be presenting at LSI Europe23 Medtech Summit in September. We are looking forward to connecting with other innovators and experts in medtech industry in Barcelona.